These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29679795)

  • 21. Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging.
    Lee PC; Lin CY; Peng CL; Shieh MJ
    Biomater Sci; 2016 Nov; 4(12):1742-1753. PubMed ID: 27722406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance.
    Zhao S; Tan S; Guo Y; Huang J; Chu M; Liu H; Zhang Z
    Biomacromolecules; 2013 Aug; 14(8):2636-46. PubMed ID: 23815156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oxaliplatin(iv) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment.
    Lim WQ; Phua SZF; Chen H; Zhao Y
    Chem Commun (Camb); 2018 Nov; 54(90):12762-12765. PubMed ID: 30370905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
    Liu H; Xu H; Zhang C; Gao M; Gao X; Ma C; Lv L; Gao D; Deng S; Wang C; Tian Y
    Pharm Res; 2016 Nov; 33(11):2828-43. PubMed ID: 27511028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
    Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
    Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visible Light and pH Responsive Polymer-Coated Mesoporous Silica Nanohybrids for Controlled Release.
    Wang G; Dong J; Yuan T; Zhang J; Wang L; Wang H
    Macromol Biosci; 2016 Jul; 16(7):990-4. PubMed ID: 26938147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prominent anchoring effect on the kinetic control of drug release from mesoporous silica nanoparticles (MSNs).
    Tran VA; Lee SW
    J Colloid Interface Sci; 2018 Jan; 510():345-356. PubMed ID: 28961433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed micelles based on a pH-sensitive prodrug and TPGS for enhancing drug efficacy against multidrug-resistant cancer cells.
    Sun D; Lv X; Wang X; Yu A; Wang Y
    Colloids Surf B Biointerfaces; 2017 Nov; 159():419-426. PubMed ID: 28823972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
    Anbharasi V; Cao N; Feng SS
    J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
    Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
    Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.
    Ravera M; Perin E; Gabano E; Zanellato I; Panzarasa G; Sparnacci K; Laus M; Osella D
    J Inorg Biochem; 2015 Oct; 151():132-42. PubMed ID: 26277416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines.
    Gao L; Wang X; Ma J; Hao D; Wei P; Zhou L; Liu G
    Colloids Surf B Biointerfaces; 2016 Apr; 140():307-316. PubMed ID: 26764117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
    Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.